CLINICAL_TRIALS
trial_result
· 2021-02-24
Clinical Trial Update: A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer [Phase 1]
Summary
Phase 1 study of AMG 211 in advanced gastrointestinal cancer was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: GI Adenocarcinoma | Phase 1 | Status: TERMINATED | Results posted: 2021-02-24